CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY FUNDAMENTALS EXPLAINED

In Section A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to discover Protected dosing regimen. Supplemental contributors are going to be enrolled within the determined monotherapy dosign regimen. In Section B, individuals will acquire oral ruxolitinib and ABBV-744 might be provided as "add-on" therapy. In Section